Quantitative Metabolite Biomarker Analysis in Human Tissues
We combine pathology and metabolomics to discover and implement new biomarkers of human disease. We primarily focus on on cytology specimens (Cytabolomics©). Metabolites are small molecules that store energy, carry messages, and serve as building blocks. Changes in ways glucose is used for energy were early discoveries about cancer. Genes, diet, drugs, and activity all rapidly affect metabolism. We do histology and quantitate metabolites using a single intact human tissue biopsy. In an era of great progress in genetics and medicine, it is easy to assume that large amounts of tissue are available for increasingly powerful testing. Trends in radiology and oncology are in the opposite direction. A biopsy the width of a pencil lead can be used to start definitive treatment, often shrinking tumors, before surgical treatment. The unexposed or treatment naïve tumor available for testing is therefore small and getting smaller.
Cytabolomics©
Intellectual property
Provia Biologics holds patent 8,980,548 Methods and Reagents for Metabolomics and Histology in a Biological Sample and A Kit for Same. and consulting.
metabolomics
Metabolites are the messenger and energy generating molecules in cells. They are about the size of glucose. They are measured by either mass spectroscopy or nuclear magnetic resonance (NMR). Advances in mass spectroscopy and data management have enabled the measurement of thousands of metabolites. Cytabolomics© can be as important to histopathology as clinical chemistry is to analysis of blood. Poorly understood diseases such as cancer, autoimmune diseases, transplant rejection, and inflammatory bowel disease/colitis are all current or future areas of interest.
Contact
➤ LOCATION
124 East 40th Street
Norfolk, VA 23504
☎ CONTACT
dtroyer@me.com
757-763-8302
Get in touch with us, or use the contact form at the bottom of this page. We are interested in collaborations and consulting.
Let's Chat.
Contact us Below